Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Incomplete Reporting of Potential Conflicts of Interest

Incomplete Reporting of Potential Conflicts of Interest Letters Incomplete Reporting of Potential Conflicts of Interest: In the Viewpoint entitled “Pharmaceutical Marketing for Rare Diseases: Regulating Drug Com- Guidelines for Letters pany Promotion in an Era of Unprecedented Advertisement,” the conflict of interest disclosures paragraph was incomplete. The paragraph should read as Letters discussing a recent JAMA article should be submitted within 4 follows: “Conflict of Interest Disclosures: All authors have completed and sub- weeks of the article's publication in print. Letters received after 4 weeks mitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. will rarely be considered. Letters should not exceed 400 words of text Dr Mailankody was supported in part by the National Cancer Institute MSK Can- cer Center Support Grant/Core Grant (P30 CA008748). Dr Prasad reports and 5 references and may have no more than 3 authors. Letters report- receiving royalties from his book Ending Medical Reversal; that his work is ing original research should not exceed 600 words of text and 6 refer- funded by the Laura and John Arnold Foundation; that he has received hono- ences and may have no more than 7 authors. They may include up to 2 raria for grand rounds/lectures from several universities, medical centers, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Incomplete Reporting of Potential Conflicts of Interest

JAMA , Volume 320 (4) – Jul 24, 2018
Download PDF
1 page

Incomplete Reporting of Potential Conflicts of Interest

Abstract

Letters Incomplete Reporting of Potential Conflicts of Interest: In the Viewpoint entitled “Pharmaceutical Marketing for Rare Diseases: Regulating Drug Com- Guidelines for Letters pany Promotion in an Era of Unprecedented Advertisement,” the conflict of interest disclosures paragraph was incomplete. The paragraph should read as Letters discussing a recent JAMA article should be submitted within 4 follows: “Conflict of Interest Disclosures: All authors have completed and sub-...
Loading next page...
 
/lp/american-medical-association/incomplete-reporting-of-potential-conflicts-of-interest-MBSxzHx612

References (2)

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.9757
Publisher site
See Article on Publisher Site

Abstract

Letters Incomplete Reporting of Potential Conflicts of Interest: In the Viewpoint entitled “Pharmaceutical Marketing for Rare Diseases: Regulating Drug Com- Guidelines for Letters pany Promotion in an Era of Unprecedented Advertisement,” the conflict of interest disclosures paragraph was incomplete. The paragraph should read as Letters discussing a recent JAMA article should be submitted within 4 follows: “Conflict of Interest Disclosures: All authors have completed and sub- weeks of the article's publication in print. Letters received after 4 weeks mitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. will rarely be considered. Letters should not exceed 400 words of text Dr Mailankody was supported in part by the National Cancer Institute MSK Can- cer Center Support Grant/Core Grant (P30 CA008748). Dr Prasad reports and 5 references and may have no more than 3 authors. Letters report- receiving royalties from his book Ending Medical Reversal; that his work is ing original research should not exceed 600 words of text and 6 refer- funded by the Laura and John Arnold Foundation; that he has received hono- ences and may have no more than 7 authors. They may include up to 2 raria for grand rounds/lectures from several universities, medical centers,

Journal

JAMA – American Medical Association

Published: Jul 24, 2018

There are no references for this article.